Cargando…
Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer
BACKGROUND: Survival from gastric cancer remains poor, particularly in Western populations. Previous pre-clinical and subgroup analyses of clinical trials have suggested differing benefits from fluoropyrimidine-based chemotherapeutics for diffuse and intestinal gastric cancer. This analysis examines...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5602536/ https://www.ncbi.nlm.nih.gov/pubmed/28922362 http://dx.doi.org/10.1371/journal.pone.0183891 |